Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

5.27
-0.2200-4.01%
Pre-market: 5.24-0.0300-0.57%04:05 EDT
Volume:1.35M
Turnover:7.12M
Market Cap:101.93M
PE:-0.87
High:5.80
Open:5.80
Low:5.13
Close:5.49
52wk High:20.56
52wk Low:5.13
Shares:19.34M
Float Shares:13.25M
Volume Ratio:1.54
T/O Rate:10.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.00
PE(LYR):-0.89

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Slides 6.6%, Underperforms Peers

Dow Jones
·
Jul 14

Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jul 10

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 09

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 07

Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.d. as Chief Medical Officer

THOMSON REUTERS
·
Jul 06

Press Release: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer

Dow Jones
·
Jul 06

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 02

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.9%, Outperforms Peers

Dow Jones
·
Jun 27

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho

TIPRANKS
·
Jun 24

Mizuho Securities Cuts Price Target on Corbus Pharmaceuticals to $34 From $44, Maintains Outperform Rating

MT Newswires Live
·
Jun 23

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 18

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 18

Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating

MT Newswires Live
·
Jun 17

Corbus Pharmaceuticals Holdings : Oppenheimer Cuts Target Price to $52 From $54

THOMSON REUTERS
·
Jun 17

Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jun 12

Corbus Pharma director Winston Kung reports disposal of 2,026 common shares worth $16,026.85

Reuters
·
Jun 12